QHSLab, Inc.|5Feb 13, 4:30 PM ET

Grogan Troy James 5

5 · QHSLab, Inc. · Filed Feb 13, 2026

Form 5

Period: 2025-12-31

DirectorPresident and CEO10% Owner

Transactions

Conversion
Common
[F1]
2024-12-31$0.18/sh+213,075$38,460→ 3,892,046 total
Other
Series A-2 Convertible Preferred Stock
[F2]
2021-12-31$286078.00/sh+2,644,424$756,511,529,072→ 2,644,424 total
Exercise: $0.16From: 2021-12-30Exp: 2050-12-31→ Common Stock (2,644,424 underlying)
Other
Series A Convertible Preferred Stock
[F3]
2019-09-01$255681.00/sh+1,080,092$276,159,002,652→ 1,080,092 total
Exercise: $0.05From: 2019-09-01Exp: 2050-12-21→ Common Stock (5,400,460 underlying)

Footnotes (3)

[F1]Represents shares issued in satisfaction of dividends accrued as of December 31, 2024, on Series A-2 Convertible Preferred Stock.
[F2]Represents 2,644,424 shares of Series A-2 Preferred Stock issued to the Reporting Person on December 30, 2021, in satisfaction of convertible promissory notes in the aggregate principal amount of $286,078 together with all interest accrued thereon. The Series A-2 Convertible Preferred Stock bears a cumulative dividend which accrues at the rate of 7% per annum. Each share of Series A Convertible Preferred stock has a stated value of $0.16 and is convertible into common stock at a price of $0.16 per share.
[F3]Represents 1,080,92 shares of Series A Preferred Stock issued to the Reporting Person on September 1, 2019, in satisfaction of convertible promissory notes in the aggregate principal amount of $255,681 together with all interest accrued thereon. The Series A Convertible Preferred Stock does not bear a dividend. Each share of Series A Convertible Preferred stock has a stated value of $0.25 and is convertible into common stock at a price of $0.05 per share.

Signature

/s/ Troy Grogan|2026-02-13

Documents

1 file